Responding to customer needs with ergonomic design
![](/46/pdcnewsitem/04/18/18/LHC-Combined_F1CT_and_F1%20(1).jpg)
Redesigned Thermo Scientific Finnpipette F1 and F1-ClipTip pipettes now have added features designed to improve user comfort and productivity (Photo: Business Wire)
Enhancements to Thermo Scientific Finnpipette F1 and F1-ClipTip pipetting systems improve comfort.
Two pipetting systems designed for accurate liquid transfer in a range of applications spanning high-throughput pharmaceutical and biotechnology laboratories to small academic and industrial laboratories are now redesigned for enhanced comfort.
For decades, Thermo Scientific Finnpipette pipetting systems have been designed for exceptional productivity and ergonomic utility across thousands of laboratories and applications worldwide. The redesigned Finnpipette F1 pipettes and Thermo Scientific F1-ClipTip pipettes now have added features designed to improve user comfort and productivity:
“Effective liquid handling is critical to ensuring experimental accuracy and as such, users need dispensing tools that can repeatedly and reliably deliver accurate volumes,” said Kelly Miller, business director of liquid handling consumables, at Thermo Fisher Scientific. “When designing upgrades for our ClipTip and Finnpipette systems, we spent time talking to our existing customers to identify their common pain points and set out to enhance their user experience. One result of the new lightweight design is that it supports the reduction of hand fatigue, and the lower pipetting forces will decrease the risk of RSI during extended use.”
These two pipetting systems are uniquely designed for different application needs. F1-ClipTip pipettes feature an interlocking tip attachment that ensures a complete seal on every channel with minimal attachment and ejection force. Once attached, the tips are locked firmly in place and are designed not to loosen or fall off, regardless of application pressure. The F1-ClipTip pipettes are designed for medium-to-high-throughput laboratories that are concerned with ergonomics, sample security, speed and improved accuracy. The Finnpipette F1 pipettes deliver the same ergonomic benefit in a lightweight design that maximizes user comfort and reduces strain. The Super Blow-out technology for effective delivery of microvolumes makes the Finnpipette F1 an ideal system for applications that use expensive reagents and valuable samples.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance